By Chris Wack
Nanox Imaging Ltd. shares were up 15% to $32.25 after the company said it has submitted a 510(k) premarket notification application to the U.S. Food and Drug Administration for the first version of its multisource Nanox.ARC 3-D digital tomosynthesis system.
The company said the first version of the multisource Nanox.ARC will be followed by future Nanox.ARC versions.
Nanox.ARC is a 3-D tomosynthesis imaging system that produces scans of a human body part. The system is being designed for easy setup and operation with multiple alternately switched X-ray tubes arranged around the patient.
Nanox received FDA clearance of its single source Nanox Cart X-Ray System in April.
Write to Chris Wack at email@example.com
(END) Dow Jones Newswires